Recombinant implies combining different components. PTH- Parathyroid Horm1: Hormone which is responsible to work in our body to regulate calcium levels. Next, so we all know what the word "Manufacturing" is, making something out of machines and technology. With all these words combined then it gives us Yaohai 재조합 돼지 인슐린 바이오제조 그리고 기계를 이용해 부갑상선 호르몬을 만드는 것, 그 부분들을 똑똑하게 결합하는 것으로 정의할 수 있습니다.
PTH는 과학자들이 수년간 구축한 재조합형으로 다시 새로운 것입니다. 이것은 박테리아라는 작은 유기체에서 사용되며 부갑상선 호르몬을 개발하기 위해 특정 단백질을 사용합니다. 이러한 시장 리더 중 하나는 Yaohai입니다. 그들은 재조합형 PTH에 대한 독창적이고 혁신적인 공정을 개발했습니다.
박테리아를 요리하기 위해, 그들은 먼저 DNA(작은 벌레들에게 언제, 어디서 켜야 하는지 알려주는 마법의 요리책)를 휘젓습니다. 그런 다음, 그들은 이 DNA를 박테리아에 넣습니다. 그런 다음 그들은 실험실에서 이 박테리아를 키웁니다. 야오하이 GMP 재조합 펩타이드 제조 releases the PTH hormone, which causes them to reproduce just like we do, and make more PTH. So alchemy is an effective way to get lots of this hormone.
Supine PTH Productions On top of that, this resource additionally aids to produce a lot more budget-friendly the techniques with PTH Items quality for consumers. PTH is produced through conventional methods that are expensive as they are based on animals and human PTH. This can be a time-consuming and resource-intensive approach, particularly when you have to synthesize large quantities of the hormone.
대조적으로, 재조합 PTH 제조는 박테리아를 사용하여 해당 호르몬을 만든다는 점을 제외하면 어렵고 비쌉니다. 재조합 PTH를 생성하는 새로운 프로세스는 더 빠르고 간단한 프로세스입니다. 이를 통해 각 의사는 취급 및 조달/투여에 비용이 들지 않으므로 PTH 치료를 할인된 가격으로 제공할 수 있습니다. 즉, 더 많은 사람들이 자격이 있는 도움을 받고 매우 비싼 비용에 대해 너무 걱정하지 않을 수 있습니다.
이것은 의학 분야의 획기적인 진전이라고 할 수 있으며, 재조합 PTH 제조가 있습니다. 이 방법은 치료에 필수적인 PTH 호르몬을 만드는 훨씬 쉽고 저렴한 방법을 제공합니다. 이제 환자는 비용이 얼마나 들 것인지에 대한 걱정 없이 치료를 받을 수 있습니다. 보도에 따르면, 이는 그러한 치료가 필요한 많은 사람들에게 큰 안도감을 주었습니다.
재조합 PTH도 예측이 가능하며, 이는 다음의 주요 이점으로 이어집니다. 기존의 PTH(예: 여러 출처에서 추출되어 종종 다름)와 달리 결과는 기존 PTH와 다를 수 있습니다. Yaohai 재조합 파킨 단백질 제조 통제된 환경에서 제조되므로 품질 결과가 매번 보장됩니다. 정기적인 치료가 필요한 환자는 이러한 일관성에서 진정한 가치를 볼 수 있습니다.
Yaohai Bio-Pharma is a leading in Recombinant PTH Manufacturing CDMO. Our main focus has been the production of microbial vaccinations and therapeutics to treat pets, human and veterinary health. We possess cutting-edge RD and manufacturing technology platforms that cover the entire manufacturing process from the engineering of microbial strains, to cell banking processing and method design to clinical and commercial manufacturing, making sure that we can ensure the successful delivery of the most advanced solutions. We have accumulated a huge quantity of knowledge in the bio processing microbial field. More than 200 projects have been successfully completed and we help our clients comply with regulations like those of the US FDA as well as EU EMA. We also help them to navigate Australia TGA and China NMPA. We are able to respond rapidly to market requirements and offer customized CDMO services due to our experience and expertise.
Recombinant PTH Manufacturing has experience in manufacturing biologics that are that are derived from microorganisms. We provide tailored RD as well as manufacturing solutions, while minimising the risk. We have experimented with a variety of techniques, such as recombinant cellular subunits of vaccines (including peptides), growth factors, hormones and the cytokines. We have specialized in multiple microorganisms like yeast extracellular and intracellular secretion (yields up to 15g/L) and bacteria intracellular soluble and inclusion bodies (yields up to 10g/L). We also have the BSL-2 fermentation platform to develop bacterial vaccines. We are experts in improving processes, increasing product yields, and decreasing production costs. With an effective technology team, we ensure timely and quality project delivery and bring your products to market faster.
Yaohai Bio-Pharma, a top 10 producer of biological products, is a specialist in microbial fermentation. We have established an advanced facility that is equipped with modern facilities and strong RD manufacturing capabilities. We have five drug substance manufacturing lines that are in compliance with GMP requirements for microbial fermentation and purification, as well as two fill-finish lines that are automated for cartridges, vials, as well as pre-filled syringes. The available fermentation scales vary from 100L to 500L, 1000L and 2000L. Recombinant PTH Manufacturing for vias are 1ml to 25ml, whereas the pre-filled syringes and cartridge filling specifications cover 1-3ml. Our production workshop is cGMP compliant and guarantees steady supply of clinical samples as well as commercial items. Our plant produces large molecules which are shipped to the globe.
Yaohai BioPharma is a Top 10 Microbial CDMO that incorporates quality management and regulatory issues. We have developed a solid quality management system that conforms to the current GMP standards and regulations globally. Our regulatory team has an in-depth understanding of the world-wide regulatory frameworks. This allows us to accelerate biological launches. We ensure traceable production processes as well as high-quality products and in compliance with the guidelines of the US FDA and EU EMA. Recombinant PTH Manufacturing and China NMPA are also satisfied. Yaohai BioPharma successfully passed an on-site audit conducted by an accredited Qualified Person of the European Union (QP) to review our GMP system and production facility. We have also been through the first certification audits of the ISO9001 Quality Management System and ISO14001 Environmental Management System.
Yaohai Bio-Pharma는 14년 동안 미생물 CRDMO 솔루션에 주력해 왔습니다. 우리는 전 세계 고객에게 원스톱 생물학적 제제 서비스를 제공합니다.
No. 801, Jiankang Avenue, Taizhou, Jiangsu, China
저작권 © 야오하이 바이오제약 주식회사 판권 소유 | 개인정보 처리방침
EN
AR
HR
CS
DA
NL
FI
FR
DE
EL
IT
JA
KO
아니
PL
PT
RO
RU
ES
SV
IW
ID
LV
LT
SR
SK
SL
UK
VI
ET
HU
TH
TR
FA
AF
MS
BE
MK
UR
BN
